Dentsply Sirona Appoints Mark R. Bezjak as Group Vice President, Americas Regional Commercial Organization
Rhea-AI Summary
Dentsply Sirona (Nasdaq: XRAY) appointed Mark R. Bezjak as Group Vice President, Americas Regional Commercial Organization, effective January 28, 2026. The hire is intended to strengthen commercial execution, deepen customer relationships and accelerate growth across the Americas. Bezjak joins from Zimmer Biomet, brings more than 20 years of commercial leadership and experience leading multi‑billion‑dollar organizations, and has a track record of commercial transformations and revenue and operating income growth. Management highlights his experience in orthopedics and customer‑first field execution as aligned with the company’s goal to elevate service to the dental community.
Positive
- Appointment effective Jan 28, 2026
- Executive with 20+ years commercial experience
- Proven leadership of multi‑billion‑dollar organizations
- Background from Zimmer Biomet, President of Americas division
- Track record of commercial transformations and margin growth
Negative
- None.
News Market Reaction
On the day this news was published, XRAY declined 2.19%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
XRAY rose 2.4% with elevated volume while peers showed mixed moves: NVST 0.13, LMAT 0.02, ICUI 1.13 versus WRBY -1.36 and MMSI -5.71. No broad, unified sector move is indicated.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| 2026-01-06 | Conference presentation | Neutral | +0.0% | J.P. Morgan Healthcare Conference presentation on strategy and Connected Dentistry. |
| 2025-12-15 | Dividend announcement | Positive | -1.5% | Quarterly cash dividend declaration with indicated annual payout rate. |
| 2025-11-06 | Earnings results | Negative | -12.7% | Q3 2025 sales decline, large impairments, net loss, and lowered guidance. |
| 2025-10-08 | Earnings call setup | Neutral | -1.3% | Announcement of timing and access details for Q3 earnings call. |
| 2025-10-02 | Leadership change | Positive | +0.1% | Appointment of new Chief Commercial Officer and customer-centric reorganization. |
Recent news has often been tied to leadership and strategic updates, with generally modest price reactions except for a sharper decline on weak Q3 results.
Over the past few months, Dentsply Sirona has focused on its return-to-growth strategy and leadership realignment. In Q3 2025, the company reported $904M in net sales and a $427M GAAP net loss, which drove a notable negative reaction. Subsequent announcements included a new Chief Commercial Officer on October 6, 2025, routine conference and presentation updates, and a $0.16 quarterly dividend. Today’s Americas commercial leadership appointment fits into this ongoing commercial and execution-focused repositioning.
Market Pulse Summary
This announcement adds another experienced commercial leader to Dentsply Sirona’s Americas organization, supporting its focus on strengthening execution and customer engagement. It follows earlier changes such as the new Chief Commercial Officer and the Q3 return-to-growth plan. Investors may track how this leadership team affects net sales, margins, and regional performance in upcoming quarters, alongside any further updates in SEC filings and earnings disclosures.
AI-generated analysis. Not financial advice.
CHARLOTTE, N.C., Jan. 12, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY), the world’s largest diversified manufacturer of professional dental products and technologies, today announced the appointment of Mark R. Bezjak as Group Vice President, Americas Regional Commercial Organization, effective January 28.
The appointment supports Dentsply Sirona’s continued focus on strengthening commercial execution, deepening customer relationships and accelerating growth across the Americas. Mr. Bezjak is a seasoned commercial executive with more than 20 years of experience leading large-scale, multi-billion-dollar organizations in the medical device industry. He joins Dentsply Sirona from Zimmer Biomet, a global medical technology company, where he most recently served as President of the Americas division. Throughout his career, he has led comprehensive commercial transformations, advanced technology-enabled solutions and delivered consistent revenue and operating income growth.
“Mark’s appointment is a critical step in ensuring we have the right leadership in place to execute our growth strategy,” said Aldo Denti, EVP, Chief Commercial Officer of Dentsply Sirona. “He brings deep commercial expertise, a strong customer-first mindset and a proven ability to build high-performing teams, modernize go-to-market strategies, and drive disciplined growth. His experience in Orthopedics—a highly demanding, customer-first market where success depends on close clinician engagement, rapid problem-solving, and strong field execution—aligns perfectly with our goal of elevating customer focus and strengthening how we serve the dental community.”
Mr. Bezjak said, “I am excited to join Dentsply Sirona at an important moment for the company. I look forward to working closely with Aldo and the broader leadership team to strengthen commercial execution, support our customers and build a foundation for sustained growth across the Americas.”
About Mark R. Bezjak
Mr. Bezjak held multiple senior leadership roles at Zimmer Biomet, including President of the Americas, President of North America, and Vice President and General Manager, North America. He has extensive experience in medical device, commercial transformation, financial management and technology-driven growth initiatives. At Zimmer Biomet, Mr. Bezjak led the commercial transition from an implant to a technology company, developed commercial go-to-market strategies for new products, drove pricing strategies and transformed commercial organizations to drive enhanced sales and profitability goals. Before joining Zimmer Biomet in 2008, he worked for Arrow International and Michelin North America. Mr. Bezjak holds a Bachelor of Science in Marketing from Virginia Polytechnic Institute and State University (Virginia Tech) and an MBA from the University of Richmond.
About Dentsply Sirona
Dentsply Sirona is the world’s largest diversified manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a strong portfolio of world-class brands. Dentsply Sirona’s innovative products provide high-quality, effective and connected solutions to advance patient care and deliver better and safer dental care. Dentsply Sirona’s headquarters is located in Charlotte, North Carolina. The Company’s shares are listed in the United States on Nasdaq under the symbol XRAY. Visit www.dentsplysirona.com for more information about Dentsply Sirona and its products.
Contact Information
Investors:
Wade Moody
Senior Manager, Investor Relations
InvestorRelations@dentsplysirona.com
FAQ
When does Mark R. Bezjak start as Group Vice President at Dentsply Sirona (XRAY)?
What role will Mark R. Bezjak hold at Dentsply Sirona (XRAY)?
What experience does Mark R. Bezjak bring to Dentsply Sirona (XRAY)?
Where did Mark R. Bezjak work before joining Dentsply Sirona (XRAY)?
Why did Dentsply Sirona (XRAY) appoint Mark R. Bezjak?
How does Bezjak’s background in orthopedics relate to his role at Dentsply Sirona (XRAY)?
